Cargando…
Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome
BACKGROUND: Elabela (ELA) was newly discovered as a novel endogenous ligand of the apelin receptor (APJ) which has demonstrated to be crucial for cardiovascular disease such as myocardial infarction, hypertension and heart failure. Previous experiments have revealed that ELA reduced arterial pressur...
Autores principales: | DU, Sheng-Li, YANG, Xin-Chun, ZHONG, Jiu-Chang, WANG, Le-Feng, FAN, Yi-Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729181/ https://www.ncbi.nlm.nih.gov/pubmed/33343646 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.004 |
Ejemplares similares
-
Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study
por: Ma, Zheng, et al.
Publicado: (2021) -
Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
por: Bae, Kwi-Hyun, et al.
Publicado: (2018) -
Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
por: Ma, Zheng, et al.
Publicado: (2021) -
Association of Serum Prealbumin with Angiographic Severity in Patients with Acute Coronary Syndrome
por: Zhang, Chenglong, et al.
Publicado: (2017) -
The Elabela-APJ axis: a promising therapeutic target for heart failure
por: Ma, Zheng, et al.
Publicado: (2020)